Technical Articles
UA010811
Why Biotinylated Cynomolgus PD-1 Anchors Preclinical Species Bridging
Toxicology and PD studies in cynomolgus monkeys need matching reagents. This article positions the biotinylated probe inside the species-bridging evidence chain.
View details
- Immunity/Inflamma
- biotinylated PD-1
- preclinical evaluation
- species bridging
- target occupancy
- functional blocking
- UA010811
Receptor-Occupancy Assays with Biotinylated Cynomolgus PD-1: Solid-Phase Options and Four Steps
A four-step receptor-occupancy workflow using biotinylated cyno PD-1: capture orientation, blocking, sample incubation and detection, with solid-phase tradeoffs.
View details
- Immunity/Inflamma
- biotinylated PD-1
- receptor occupancy
- streptavidin
- direct coating
- bridging assay
- UA010811
What Biotinylated Cynomolgus PD-1 Changes in Preclinical Reading: Species and Biotinylation Site
Cynomolgus PD-1 sits between human and mouse readouts, and the Avi-tag biotin site fixes probe orientation. This article maps how both change interpretation.
View details
- Immunity/Inflamma
- biotinylated PD-1
- PD-1
- cynomolgus
- Avi Tag
- streptavidin
- cross-reactivity
- UA010811
- 1








